Pathological Upgrading and Up Staging With Immediate Repeat Biopsy in Patients Eligible for Active Surveillance
Author:
Affiliation:
1. Division of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference20 articles.
1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007
2. Quality-of-life outcomes in men treated for localized prostate cancer;Litwin;JAMA,1995
3. Predicting quality of life after radical prostatectomy: results from CaPSURE;Hu;J Urol,2004
4. Active surveillance for favorable risk prostate cancer: Rationale, risks, and results;Klotz;Urol Oncol,2007
5. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results;Carter;J Urol,2002
Cited by 253 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Putting patients first to redefine prostate cancer classifications;JNCI: Journal of the National Cancer Institute;2023-07-10
2. Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active Surveillance;European Urology Focus;2022-12
3. Clinical and histological predictive factors of reclassification of prostate cancer patients on active surveillance;Actas Urológicas Españolas (English Edition);2022-07
4. Focal therapy for prostate cancer: what is really needed to move from investigational to valid therapeutic alternative?—a narrative review;Annals of Translational Medicine;2022-07
5. Factores clínicos e histológicos predictores de reclasificación en pacientes incluidos en programa de vigilancia activa de cáncer de próstata;Actas Urológicas Españolas;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3